Form D — Reprise Biomedical, Inc.
0001782236-26-000001 · filed May 21, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $8,000,000
- Total sold
- $1,450,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Reprise Biomedical, Inc.
- CIK
- 1782236
- Entity
- Corporation
- Jurisdiction
- MINNESOTA
- Year incorporated
- —
- Address
- 17400 Medina Rd., Ste. 100
Plymouth, MN 55447 - Phone
- 763-284-6780
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Carrie Powers · Executive OfficerPlymouth, MN Find on LinkedIn ↗
-
Jake Isenburg · Executive OfficerPlymouth, MN Find on LinkedIn ↗
-
Tom Kouchoukos · Executive OfficerPlymouth, MN Find on LinkedIn ↗
-
Steve Jagodzinski · Executive OfficerPlymouth, MN Find on LinkedIn ↗
-
Greg Smock · Executive OfficerPlymouth, MN Find on LinkedIn ↗
-
Jerrod Krueger · Executive OfficerPlymouth, MN Find on LinkedIn ↗
-
Heather Kotila · Executive OfficerPlymouth, MN Find on LinkedIn ↗
-
Howard Root · DirectorPlymouth, MN Find on LinkedIn ↗
-
Ronald Eibensteiner · DirectorPlymouth, MN Find on LinkedIn ↗
-
Erwin Kelen · DirectorPlymouth, MN Find on LinkedIn ↗
-
Phil Nalbone · DirectorPlymouth, MN Find on LinkedIn ↗
-
Alan Woldt · DirectorPlymouth, MN Find on LinkedIn ↗
-
Jeff Duncan · Executive OfficerPlymouth, MN Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗